Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130210015M |
| Application |
Infection |
The kit has been designed for the qualitative determination of Hepatitis C virus antibody (Anti-HCV) in human serum. The test has to be performed on MAGLUMI Fully-auto chemiluminescence immunoassay (CLIA) analyzer (Including Maglumi 600, Maglumi 800, Maglumi 1000, Maglumi 1000 Plus, Maglumi 2000, Maglumi 2000 Plus, Maglumi 4000 and Maglumi 4000 Plus).
Rapid and Reliable HCV ScreeningThe Snibe MAGLUMI Anti-HCV (CLIA) kit stands out for its rapid turnaround time-delivering accurate results in 35 minutes or less. With a high throughput of up to 180 tests per hour and an automatic operation system, it is ideal for busy clinical laboratories and blood banks. Precision calibration and quality control materials included in the kit guarantee dependable and reproducible results for HCV antibody detection.
Advanced Chemiluminescence Immunoassay TechnologyThis immunoassay analyzer utilizes chemiluminescence immunoassay (CLIA) technology, offering high specificity and sensitivity in detecting Hepatitis C antibodies. The use of only 10-80 L of human serum or plasma makes it efficient and cost-effective, while automated batch or real-time testing modes enhance operational flexibility. The system is reliable, accurate, and reduces manual labor with real-time data display and analysis.
User-Centric Design and Efficient OperationDesigned for ease of use, the analyzer features an LCD touchscreen interface, low noise operation, and supports both single and batch tests. The kit is complete with control materials, ensuring each run is compliant with rigorous quality assurance standards. It operates on standard electrical supplies and fits seamlessly in laboratory settings, providing uninterrupted, high-throughput performance.
FAQ's of Snibe MAGLUMI Anti-HCV (CLIA):
Q: How does the Snibe MAGLUMI Anti-HCV (CLIA) kit detect HCV antibodies?
A: The kit uses chemiluminescence immunoassay (CLIA) technology to qualitatively detect Hepatitis C virus (HCV) antibodies in human serum or plasma samples, providing automated, precise results rapidly.
Q: What types of samples are required for testing with this kit?
A: The analyzer requires human serum or plasma as sample types, using a volume between 10 and 80 L for each test.
Q: When are the results available after starting a test?
A: Results are provided in 35 minutes or less, enabling swift decision-making for screening, diagnosis, or blood donor testing.
Q: Where is this product typically used?
A: This kit is designated for laboratory environments, such as hospital laboratories, diagnostic centers, and blood banks, and is not designed for at-home or field testing.
Q: What is the process for operating the analyzer?
A: Operation is fully automatic-simply load the samples, select your run type (single or batch) on the LCD touchscreen, and the system processes, analyzes, and displays results with minimal user intervention.
Q: What are the key benefits of using the Snibe MAGLUMI Anti-HCV (CLIA) kit?
A: The main benefits include highly specific and sensitive HCV detection, rapid turnaround times, high throughput (up to 180 tests/hour), user-friendly automation, built-in quality controls, and adaptability to various laboratory workflows.
Q: How should the kit and reagents be stored?
A: All consumables and reagents should be kept at 2-8C and protected from light to maintain performance throughout their 12-month shelf life.